South Korean airlines bank on China routes for profit recovery

South Korean airlines bank on China routes for profit recovery

South Korean airlines are ramping up international routes, particularly to China, Japan and Southeast Asian countries, in a bid to boost profitabili...

Blackstone in talks to acquire Korea’s top salon chain Juno Hair in $590 mn deal

Blackstone in talks to acquire Korea’s top salon chain Juno Hair in $590 mn deal

US private equity firm Blackstone Inc. is pursuing the acquisition of Juno Hair, South Korea’s largest premium hair salon chain, in a deal tha...

China bans export of Korean goods containing its rare earth metals to US

China bans export of Korean goods containing its rare earth metals to US

The Chinese government has warned South Korean companies of retributions for exporting any product containing its critical metals to US military con...

Celltrion wins Australian approval for eye, bone disease biosimilars

Celltrion wins Australian approval for eye, bone disease biosimilars

Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...

ABL Bio lands $2.8 billion license-out deal with GSK

ABL Bio lands $2.8 billion license-out deal with GSK

ABL Bio Inc., a South Korean biotech company, will license out its proprietary blood-brain barrier shuttle platform, called the Grabody-B, to UK-bas...

Samsung to invest $10 million in US-based C2N Diagnostics

Samsung to invest $10 million in US-based C2N Diagnostics

Samsung Group companies will jointly invest $10 million in C2N Diagnostics LLC, a U.S.-based company specializing in blood-based Alzheimer’s d...

Celltrion wins EU approval for autoimmune disease treatment Avtozma

Celltrion wins EU approval for autoimmune disease treatment Avtozma

Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...

SK Ecoplant, BMW team up for battery recycling

SK Ecoplant, BMW team up for battery recycling

SK Ecoplant Co., a South Korean construction engineering and waste management company under SK Group, partnered with German luxury carmaker BMW to...

Celltrion obtains approval of Steqeyma from FDA

Celltrion obtains approval of Steqeyma from FDA

South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...

GC Biopharma acquires ABO Holding for $96 mn

GC Biopharma acquires ABO Holding for $96 mn

South Korea’s GC Biopharma Corp. said on Thursday it acquired the US-based medical-grade source blood plasma company ABO Holding Inc. The...

Celltrion releases Steqeyma in Europe

Celltrion releases Steqeyma in Europe

South Korea's Celltrion Inc. said on Monday it released Steqeyma (ustekinumab) in Europe, the biosimilar of autoimmune disease treatment Stelara.T...

Celltrion's Zymfentra gets 90% distribution channel in US

Celltrion's Zymfentra gets 90% distribution channel in US

South Korean biosimilar maker Celltrion Inc. said on Monday its subcutaneous injection formulation for autoimmune diseases, Zymfentra (infliximab), ...

Celltrion's anti cancer drugs hold 90% market share in C.America

Celltrion's anti cancer drugs hold 90% market share in C.America

South Korea’s Celltrion Inc. said on Friday that its cancer treatments have captured a 90% market share in several Central American countries....

Near Brain gives hope to millions of stroke patients worldwide

Near Brain gives hope to millions of stroke patients worldwide

Strokes are the second leading cause of death and the third leading cause of disabilities globally, according to the World Health Organization.To fi...

IMBiologics transfers autoimmune disease drug tech to Huadong Pharma

IMBiologics transfers autoimmune disease drug tech to Huadong Pharma

South Korea's antibody-based biotech company IMBiologics announced on Friday that it signed a contract to transfer the technology of its autoimmune ...

Costco sells Celltrion's Yuflyma Low WAC in US

Costco sells Celltrion's Yuflyma Low WAC in US

South Korea's Celltrion Inc. announced on Tuesday that its autoimmune disease treatment Yuflyma (Low WAC, active ingredient adalimumab) is now avail...

Celltrion gets approval of Steqeyma in Canada

Celltrion gets approval of Steqeyma in Canada

South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Steqeyma, a biosimilar of the autoimmune dise...

GC Biopharma sells HK subsidiary to CR Pharm Group for $254 mn

GC Biopharma sells HK subsidiary to CR Pharm Group for $254 mn

South Korea’s GC Biopharma Corp. announced on Wednesday that it signed a share purchase agreement (SPA) to sell all its shares in its Hong Kon...

A North Korean Diplomat Managed a Rare Defection: A Flight Out of Cuba

A North Korean Diplomat Managed a Rare Defection: A Flight Out of Cuba

SEOUL—A North Korean diplomat posted in Cuba defected to South Korea with his family late last year, officials said this week, a rare esc...

GC Biopharma exports Alyglo to US

GC Biopharma exports Alyglo to US

South Korea’s major pharmaceutical company GC Biopharma Corp. announced on Monday that it shipped the initial volume of Alygro, its immunoglob...

Korea Eximbank to provide $150 mn PF to Australia

Korea Eximbank to provide $150 mn PF to Australia

The Export-Import Bank of Korea (Eximbank) announced on Tuesday that it will provide $150 million in project financing (PF) for developing a rare ea...

Hyundai Motor, Kia to develop alternative to rare earth materials

Hyundai Motor, Kia to develop alternative to rare earth materials

Hyundai Motor Co. and Kia Corp. have partnered with South Korea's universities to secure materials for vehicle electrification components.Hyundai Mo...

SoftBank to buy part of Naver's Line stake by July: CEO Miyakawa

SoftBank to buy part of Naver's Line stake by July: CEO Miyakawa

TOKYO – SoftBank Corp., which runs LY Corp., the operator of the popular mobile messenger app Line in Japan, said on Thursday it is in talks w...

Celltrion to supply Remsima, Herzuma to Peru

Celltrion to supply Remsima, Herzuma to Peru

South Korea's Celltrion Inc. announced on Thursday that it secured a contract to supply its biosimilars for autoimmune disease treatment and antican...

Samsung Bioepis gets OK to sell Stelara biosimilar in Europe

Samsung Bioepis gets OK to sell Stelara biosimilar in Europe

South Korea's Samsung Bioepis has received approval from the European Commission to sell Pyzchiva, a biosimilar of the autoimmune disease Stelara.&n...

Celltrion releases Remsima SC in Denmark

Celltrion releases Remsima SC in Denmark

South Korea's Celltrion Inc. announced on Thursday that it released its autoimmune disease treatment Remsima SC (infliximab) in Denmark. Remsima SC ...

Bio startup ArtBlood attracts $4.8 mn investment

Bio startup ArtBlood attracts $4.8 mn investment

South Korean bio startup ArtBlood, specializing in blood production for transfusion, announced on Tuesday that it successfully secured an investment...

Samsung begins new drug development for rare diseases

Samsung begins new drug development for rare diseases

Samsung Bioepis Co., a biosimilar development unit of South Korea’s top conglomerate Samsung Group, has begun its new drug development busines...

Reversing age possible in a decade: Harvard Prof. David Sinclair

Reversing age possible in a decade: Harvard Prof. David Sinclair

Humans will be able to control biological age and reverse their age in 10 years with advancements in medical science and live up to around 120, abou...

Celltrion'a autoimmune disease drug Zymfentra makes US debut

Celltrion'a autoimmune disease drug Zymfentra makes US debut

South Korean biopharmaceutical giant Celltrion Inc. said on March 17 that it has launched its new autoimmune disease treatment Zymfentra in the US m...

Kakao Pay backs out of acquisition deal for SSG Pay, Smile Pay Hanwha in talks to buy five-star hotel Paraspara Seoul Kia's Lego-like PV5 with 16 variants to hit market in July Stray Kids make K-pop history with landmark stadium show in Germany S.Korea’s most prominent business leader returns with all charges cleared